The isoprostanes: Novel prostaglandin-like products of the free radical- catalyzed peroxidation of arachidonic acid

Journal of Biomedical Science

Volumn 6, Issue 4, 1999, Pages 226-235

  Liu, Tsan ^a   Stern, Arnold ^b   Roberts, L Jackson ^c   Morrow, Jason D ^c,d  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b NEW YORK UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Eicosanoid; Free radical; Isoprostane; Lipid; Peroxidation

Indexed keywords

ARACHIDONIC ACID; FREE RADICAL; ISOPROSTANE; PROSTAGLANDIN DERIVATIVE;

ATHEROSCLEROSIS; CATALYSIS; CHEMICAL STRUCTURE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; RISK FACTOR;

EID: 0032778931     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253564     Document Type: Review

References (45)

1. Ames BN. Dietary carcinogens and anticarcinogens. Science 221:1256-1264;1983.
2. 2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res 50:1879-1885;1990.
3. Boushey CJ, Beresford SA, Omenn GS. Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057; 1995.
4. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 117:3230-3235;1997.
5. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidanls of cigarette smoke induce lipid pcroxidation and changes in lipoprotein properties in human blood plasma: Protective effects of ascorbic acid. Biochem J 277:133-138; 1991.
6. 2 and related compounds: An update. Prostaglandins Leukot Essent Fatty Acids 47:1-12;1992.
7. 2-like compounds (F-isoprostanes) are present in increased amounts in human atherosclerotic lesions. Arterioseler Thormb Vasc Biol 17:3236-3241;1997.
8. 2α is elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 368:225-229;1995.
9. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15: 129-135;1990.
10. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85; 1990.
11. Hamberg M, Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70:899-903;1973.
12. Harman D. The aging process. Proc Natl Acad Sci USA 78:7124-7128;1981.
13. 2 biosynthesis. J Biol Chem 264:141-150;1989.
14. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J 101:319-328;1981.
15. 2-isoprostane-containing phospholipids. J Lipid Res 34:1229-1235; 1993.
16. Koulouris S, Frei B, Morrow JD, Keaney JF, Vita JA. Increased oxidativc stress in patients with diabetes mellitus. Circulation 92(suppl 1 ): 1-102;1995.
17. 2α. J Biol Chem 272: 27147-27154;1997.
18. Lynch SM, Morrow JD, Roberts LJ, Frei B. Formation of non-cyclooxygenase-derived prostanoids (Fi-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 93:998-1004; 1994.
19. Maxwell SRJ, Lip GYH, Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol 44:307-317; 1997.
20. 2-isoprostane levels arc increased in Alzheimcr's disease. Ann Neurol 44:410-413; 1998.
21. 2-like compounds are produced in vivo in humans by a non-cycloocygenase, free radicalcatalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387; 1990.
22. Morrow JD, Harris TM, Roberts LJ. Noncyclooxygcnase oxidative formation of a series of novel prostaglandins: Analytical ramifications for the measurement of eicosanoids. Anal Biochcm 184:1-10;1990.
23. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest 90:2502-2507;1992.
24. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89: 10721-10725;1992.
25. Morrow JD, Minton TA, Zackert WE, Awad JA, Campbell MD, Mukundan CR, Blair IA, Badr KF, Roberts LJ. Free radical-induced generation of isoprostanes in vivo: Evidence for the formation of D-ring and E-ring compounds. J Biol Chem 269:4317-4326; 1994.
26. 2-isoprostanes) in smokers. N Engl J Med 332:1198-1203;1995.
27. Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ. Nonenzymatic free radical-catalyzed generation of thromboxanelike compounds (isothromboxanes) in vivo. J Biol Chem 271:23185-23190; 1996.
28. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1-21;1997.
29. Morrow JD, Chen Y, Zackert WE, Roberts LJ. The isoprostanes: Recent advances. In: Packer L, Ong ASH, eds. Biological Oxidants and Antioxidants: Molecular Mechanisms and Health Effects. Champaign. AOCS Press, 72-78; 1998.
30. 2 in nuclei. J Pharmacol Exp Ther 242:306-311; 1987.
31. Natarajan R, Lanting L, Gonzales N, Nadler J, Formation of F-isoprostanes in vascular smooth muscle cells by elevated glucose and growth factors. Am J Physiol 271 :H159-H165; 1996.
32. Pratico D, Reilly M, Lawson J, Delanty N, FitzGerald GA. Formation of 8-iso-prostaglandin F2α by human platelets. Agents Actions 45(suppl):27-31:1995.
33. 2α by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem 271:8919-8924;1996.
34. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, FitzGerald GA. Localization of distinct F-isoprostanes in human atherosclerotic lesions. J Clin Invest 100:2028-2034;1997.
35. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-defǐcient mice. Nat Med 4:1189-1192;1998.
36. Pryor WA, Stanley JP. A suggested mechanism for the production of malondialdehydc during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40:3615-3617;1975.
37. Pryor WA, Godber SS. Oxidativc stress status: An introduction. Free Radie Biol Med 10:173; 1991.
38. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19-25;1996.
39. Roberts LJ, Morrow JD. Isoprostancs as markers oflipid peroxidation in atherosclerosis. In: Scrhan CN, ed. Atherosclerosis and Oxidant Damage. In press.
40. Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. Nomenclature of isoprostanes: A proposal. Prostaglandins 54:853-873;1997.
41. Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 63:390-408;1988.
42. Stein CM, Tanner SB, Awad JA, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 39:1146-1150;1996.
43. Taber DF, Morrow JD, Roberts LJ. A nomenclature system for the isoprostanes. Prostaglandins 53:63-67;1997.
44. Voutilainen S, Morrow JD, Roberts LJ, Alfthan G. Alho H, Nyyssoncn K, Salonen JT. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioseler Thromb Vasc Biol, in press.
45. 2-isoprostane regioisomers formed in vivo in the rat. Free Radic Biol Med 23:943-954: 1997.